✦ LIBER ✦

LDL subclasses and lipoprotein-phospholipase A2 activity in suppressed HIV-infected patients switching to raltegravir: Spiral substudy

✍ Scribed by Maria Saumoy; José Luis Sánchez-Quesada; Esteban Martínez; Josep Maria Llibre; Esteban Ribera; Hernando Knobel; Josep Maria Gatell; Bonaventura Clotet; Adrian Curran; Jordi Curto; Margarita Masó; Jordi Ordoñez-Llanos; Daniel Podzamczer

Book ID: 118424265
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 529 KB
Volume: 225
Category: Article
ISSN: 0021-9150
DOI: 10.1016/j.atherosclerosis.2012.08.010

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Switch to a raltegravir-based regimen ve

Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials

✍ Joseph J Eron; Benjamin Young; David A Cooper; Michael Youle; Edwin DeJesus; Jai 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 149 KB

A Switch in Therapy to a Reverse Transcr

A Switch in Therapy to a Reverse Transcriptase Inhibitor Sparing Combination of Lopinavir/Ritonavir and Raltegravir in Virologically Suppressed HIV-Infected Patients: A Pilot Randomized Trial to Assess Efficacy and Safety Profile: The KITE Study

✍ Ofotokun, Ighovwerha; Sheth, Anandi N.; Sanford, Sara E.; Easley, Kirk A.; Shenv 📂 Article 📅 2012 🏛 Mary Ann Liebert 🌐 English ⚖ 358 KB